Evidence map›Paper›PMID 29968754›Full record

ArticleScientific reports2018

The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy.

Meng Jiang, Zi Wang, Xuan Su, Xingrong Gong, Jun Pu, Lianming Wu, Chang Liu, Qiuying Yao, Lingcong Kong, Jianrong Xu and 1 more

Erratum issued Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04197050 (Effect of Sacubitril/Valsartan on Right Ventricular Dysfunctioning Patients With Connective Tissue Disease), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04197050 phase4unknown statusnot on this mapstarted 2020, after this paper: background citation

Effect of Sacubitril/Valsartan on Right Ventricular Dysfunctioning Patients With Connective Tissue Disease

TypeinterventionalSponsorRenJi HospitalRan2020 to 2022Enrolled60ConditionsMyocardial Injury, Connective Tissue DiseasesArmsSacubitril / Valsartan Oral Tablet
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Meng JiangDepartment of Cardiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China.
Zi WangDepartment of Cardiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China.
Xuan SuDepartment of Cardiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China.
Xingrong GongDepartment of Cardiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China.
Jun PuDepartment of Cardiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China.
Lianming WuDepartment of Radiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China.
Chang LiuDepartment of Epidemiology and Biostatistics, West China School of Public Health, Sichuan University, Chengdu, 610041, China.
Qiuying YaoDepartment of Radiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China.
Lingcong KongDepartment of Cardiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China.
Jianrong XuDepartment of Radiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China. xujrdoc10@163.com.
Ben HeDepartment of Cardiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, 200127, China. heben_rj@163.com.
Renji Hospital · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular volume (ECV) has been validated as a surrogate measure of interstitial fibrosis, that is increased in both hypertension-induced left ventricular hypertrophy (H-LVH) and hypertrophic cardiomyopathy (HCM). We aimed to explore the correlation between ECV and left ventricular cardiac function. Eighty-one patients with HCM, 44 with H-LVH and 35 controls were prospectively enrolled. Even among patients with normal diastolic function, patients in HCM group had increased- ECV. In terms of diastolic dysfunction (DD), a similar increase in ECV was associated with a larger percentage of patients with severe or moderate-to-severe DD in HCM group. In addition, there was a compensatory increase in the left ventricular ejection fraction (LVEF) in HCM, but no hyperdynamic LVEF was observed in H-LVH. ECV was negatively correlated with LVEF in the late gadolinium enhancement (+) (LGE+) subgroups in the H-LVH group, while no significant linear correlation was observed in HCM group. The increased ECV in HCM patients with normal diastolic function warrants further exploration of the prognostic value of ECV assessments in the early stages of HCM. The associations between ECV and left ventricular functional parameters differed and taking both LGE and ECV into account might be reasonable way to differentiate between the two disorders.

Indexed as

AdultAgedCardiomyopathiesCardiomyopathy, HypertrophicCase-Control StudiesChinaContrast MediaExtracellular FluidExtracellular SpaceFemaleFibrosisHeart VentriclesHumansHypertensionHypertrophy, Left VentricularMagnetic Resonance Imaging, CineContrast Media

Identifiers

PMID29968754
PMCPMC6030120
OpenAlexW2809961704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.